Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Suanfarma

02 1Curequest Lifescience

03 1NAM Group

04 1Scimplify

05 1Shamrock Medicaments

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSuanfarma, at the Core of a Better Life.

Carbonyldiimidazole

CAS Number : 530-62-1

End Use API :

About the Company : Suanfarma founded in 1993, is a B2B life science partner committed to health advancement by developing, manufacturing, & distributing high-quality APIs for the pharmaceutical industry i...

Suanfarma

02

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

1,1'-Carbonyldimidazole (CDI)

CAS Number : 530-62-1

End Use API :

About the Company : Curequest lifescience LLP is in the business of manufacturing and exports of Active Pharmaceutical Ingredients (APIs) and API Intermediates. We are a team of young techno-commercial pro...

blank

03

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

N,N-Carbonyl Di Imidazole (Cdi)

CAS Number : 530-62-1

End Use API :

About the Company : NAM Group of Industries is a prominent manufacturer and exporter of pharmaceutical API’s for both human and veterinary use, along with pharmaceutical intermediates. Our cutting-edge f...

blank

04

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

N, N-Carbonyldiimidazole (CDI)

CAS Number : 530-62-1

End Use API :

About the Company : Scimplify is a science-first company specializing in end-to-end development and manufacturing of specialty chemicals. We support the entire product life cycle, from contract research to...

blank

05

AACR Annual meeting
Not Confirmed
arrow
arrow
AACR Annual meeting
Not Confirmed

1,1-carbonyldiimidazole

CAS Number : 530-62-1

End Use API :

About the Company : Shamrock Medicaments Ltd, formerly known as Doctor Lifeline Remedies India Ltd, has an intriguing evolution. Established within the robust Shamrock Group in 2001 with a hefty $35 millio...

blank